Genprex GNPX
NASDAQ GNPX
$3.95 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genprex (GNPX) Intangibles (2016 - 2024)

Genprex (GNPX) posted quarterly Intangibles of $790466.0 for Q1 2024, up 9.52% year-over-year from $721722.0 in Q2 2023, and up 2.2% quarter-over-quarter from $773478.0 in Q4 2023.

Genprex (GNPX) Intangibles (2016 - 2024) Analysis & Trends

Genprex's Intangibles history runs 9 years deep, the most recent figure standing at $790466.0 for Q1 2024.

  • In Q1 2024, Intangibles rose 9.52% year-over-year to $790466.0; the TTM figure through Mar 2024 stood at $790466.0 (up 9.52% YoY), while the FY2023 annual figure was $773478.0, up 10.17% from the prior year.
  • Intangibles for Q1 2024 stood at $790466.0, up from $773478.0 in the prior quarter.
  • The five-year high for Intangibles was $790466.0 in Q1 2024, with the low at $534523.0 in Q2 2020.
  • The 5-year median for Intangibles is $644201.0 (2022), against an average of $661482.4.
  • The sharpest annual moves came in 2020 and 2022: Intangibles jumped 38.64% in 2020, then rose 5.49% in 2022.
  • Genprex's Intangibles stood at $601625.0 in 2020, then grew by 6.77% to $642360.0 in 2021, then increased by 9.3% to $702095.0 in 2022, then rose by 10.17% to $773478.0 in 2023, then rose by 2.2% to $790466.0 in 2024.
  • Business Quant data shows GNPX's Intangibles at $790466.0 in Q1 2024, $773478.0 in Q4 2023, and $763478.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 412.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.31 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 266.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 60.96 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 93.49 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Genprex 1.88 Mn -13.28 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 790,466.00
Dec 31, 2023 773,478.00
Sep 30, 2023 763,478.00
Jun 30, 2023 741,722.00
Mar 31, 2023 721,722.00
Dec 31, 2022 702,095.00
Sep 30, 2022 682,097.00
Jun 30, 2022 666,049.00
Mar 31, 2022 644,201.00
Dec 31, 2021 642,360.00
Sep 30, 2021 627,360.00
Jun 30, 2021 619,673.00
Mar 31, 2021 610,696.00
Dec 31, 2020 601,625.00
Sep 30, 2020 587,712.00
Jun 30, 2020 534,523.00
Mar 31, 2020 535,944.00
Dec 31, 2019 491,200.00
Sep 30, 2019 423,923.00
Jun 30, 2019 421,473.00